We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis announced that it will acquire the UK-based ocular gene therapy company Gyroscope Therapeutics, giving Novartis a one-time gene therapy for geographic atrophy (GA), a leading cause of blindness. Read More
In a purchase aimed at broadening its portfolio of cancer therapies, Sanofi is acquiring San Francisco, Calif.-based Amunix Pharmaceuticals for $1 billion. Read More
Australian biotech firm CSL will purchase Swiss pharmaceutical company Vifor Pharma for $11.7 billion in a deal set to close in mid-2022, the companies announced. Read More
The new team will support Joaquin Duato, the company’s current vice chairman, who is set to take the reins as CEO from Alex Gorsky after the new year. Read More